Microbot Operating Income from 2010 to 2025
| MBOT Stock | USD 2.92 0.04 1.39% |
Operating Income | First Reported 1991-03-31 | Previous Quarter -3 M | Current Value -3.7 M | Quarterly Volatility 4.9 M |
Check Microbot Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Microbot Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 86.5 K, Interest Expense of 158.5 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 302, Dividend Yield of 79.82 or PTB Ratio of 5.21. Microbot financial statements analysis is a perfect complement when working with Microbot Medical Valuation or Volatility modules.
Microbot | Operating Income | Build AI portfolio with Microbot Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Microbot Stock Analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.